TSS
CANF

Two Sigma Securities’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Two Sigma Securities’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-604
Closed -$2.42K – 1702
2025
Q4 		$2.42K Buy
604
+72
+14% +$564 ﹤0.01% 1368
2025
Q3 		$6.59K Sell
532
-271
-34% -$4.14K ﹤0.01% 1243
2025
Q2 		$16.9K Buy
+803
New +$18.5K ﹤0.01% 1238
2025
Q1 		– Sell
-970
Closed -$31.5K – 1529
2024
Q4 		$31.5K Sell
970
-509
-34% -$20.6K ﹤0.01% 1242
2024
Q3 		$59.4K Buy
+1,479
New +$79.2K ﹤0.01% 2355
2023
Q1 		– Sell
-135
Closed -$16.5K – 2698
2022
Q4 		$16.5K Buy
135
+62
+85% +$9.62K ﹤0.01% 2294
2022
Q3 		$11K Buy
+73
New +$12.7K ﹤0.01% 2387
2022
Q1 		– Sell
-89
Closed -$23K – 2136
2021
Q4 		$23K Buy
+89
New +$24.5K ﹤0.01% 1388
2021
Q3 		– Sell
-51
Closed -$23K – 1584
2021
Q2 		$23K Sell
51
-219
-81% -$96.1K ﹤0.01% 1443
2021
Q1 		$134K Buy
+270
New +$117K 0.01% 675
2020
Q3 		– Sell
-50
Closed -$20K – 1318
2020
Q2 		$20K Buy
+50
New +$18.4K ﹤0.01% 1290
2019
Q3 		– Sell
-65
Closed -$37K – 2074
2019
Q2 		$37K Buy
+65
New +$71.3K ﹤0.01% 1909
2018
Q4 		– Sell
-4
Closed -$17K – 2198
2018
Q3 		$17K Buy
+4
New +$15K ﹤0.01% 2459

Other funds holding CANF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's CANF Position: Q1 2026 in Review

Two Sigma Securities sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026, closing a stake of 604 shares — an estimated $2.42K sold.

Two Sigma Securities first reported a position in CANF in Q3 2018 and held it in 13 quarters. The position peaked at $134K in Q1 2021. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

  • Two Sigma Securities reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 604 Can-Fite BioPharma American Depositary Shares shares in Q1 2026, an estimated $2.42K.
  • Two Sigma Securities first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2018 and held it in 13 quarters.
  • Two Sigma Securities's Can-Fite BioPharma American Depositary Shares position peaked at $134K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.